Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.82 -0.05 (-2.93%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Lexicon Pharmaceuticals' Liabilities and Shareholders Equity was $250.06 million in Q2 2026, up 10.9% from $225.58 million a year earlier but down 7.0% from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Lexicon Pharmaceuticals came in at $184.99 million, down 38.0% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $298.42 million in FY2024 (+30.1%), $229.43 million in FY2023 (+18.1%), $194.3 million in FY2022 (+41.9%) and $136.91 million in FY2021 (-32.8%).
  • Quarterly Liabilities and Shareholders Equity has moved between $112.33 million (Q2 2022) and $417.22 million (Q1 2024) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in three of the last eight quarters, with an average decline of 11.8%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q2 2023 (growth of 182.0%); the worst was Q2 2025 (a decline of 39.6%).
  • Per Business Quant data, LXRX's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $268.82 million (Q1 2026), $184.99 million (Q4 2025) and $205.93 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Lexicon Pharmaceuticals 840.12 Mn 266.67 Mn 653,000.00 250.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 250.06 Mn
Mar 31, 2026 268.82 Mn
Dec 31, 2025 184.99 Mn
Sep 30, 2025 205.93 Mn
Jun 30, 2025 225.58 Mn
Mar 31, 2025 297.67 Mn
Dec 31, 2024 298.42 Mn
Sep 30, 2024 321.12 Mn
Jun 30, 2024 373.36 Mn
Mar 31, 2024 417.22 Mn
Dec 31, 2023 229.43 Mn
Sep 30, 2023 276.48 Mn
Jun 30, 2023 316.72 Mn
Mar 31, 2023 162.72 Mn
Dec 31, 2022 194.30 Mn
Sep 30, 2022 191.69 Mn
Jun 30, 2022 112.33 Mn
Mar 31, 2022 136.18 Mn
Dec 31, 2021 136.91 Mn
Sep 30, 2021 172.33 Mn
API Access

Lexicon Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LXRX&period=max&api_key=YOUR_API_KEY